These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 7979841

  • 1. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W, Black D, Dujovne C, Hosking JD, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle AJ.
    Arch Intern Med; 1994 Nov 14; 154(21):2449-55. PubMed ID: 7979841
    [Abstract] [Full Text] [Related]

  • 2. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M, Valacio R, Reckless JP, Ghosh AK, Findlay IN, Ghosh MK, Passmore AP, Fulcher RA.
    Coron Artery Dis; 1998 Nov 14; 9(9):583-90. PubMed ID: 9861520
    [Abstract] [Full Text] [Related]

  • 3. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 14; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 4. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 14; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 14; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study Group.
    Dallongeville J, Fruchart JC, Pfister P, Bard JM.
    J Intern Med Suppl; 1994 Jan 14; 736():95-101. PubMed ID: 7986315
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia.
    Rindone JP, Hiller D, Arriola G.
    Pharmacotherapy; 1998 Jan 14; 18(4):836-9. PubMed ID: 9692657
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Alaupovic P.
    Am J Kidney Dis; 2002 Jan 14; 39(1):67-75. PubMed ID: 11774104
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.
    Leitersdorf E, Eisenberg S, Eliav O, Friedlander Y, Berkman N, Dann EJ, Landsberger D, Sehayek E, Meiner V, Wurm M.
    Circulation; 1993 Apr 14; 87(4 Suppl):III35-44. PubMed ID: 8462179
    [Abstract] [Full Text] [Related]

  • 19. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.
    Greten H, Beil FU, Schneider J, Weisweiler P, Armstrong VW, Keller C, Klör HU, von Hodenberg E, Weidinger G, Eskötter H.
    Am J Med; 1994 Jun 06; 96(6A):55S-63S. PubMed ID: 8017468
    [Abstract] [Full Text] [Related]

  • 20. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul 06; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.